FY2025 Earnings Forecast for Cresco Labs Issued By Cormark

Cresco Labs Inc. (OTCMKTS:CRLBF) – Analysts at Cormark dropped their FY2025 EPS estimates for shares of Cresco Labs in a report released on Monday, March 17th. Cormark analyst J. Pytlak now expects that the company will post earnings per share of ($0.07) for the year, down from their prior estimate of $0.03. Cormark currently has a “Moderate Buy” rating on the stock. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share. Cormark also issued estimates for Cresco Labs’ FY2026 earnings at $0.01 EPS.

Separately, Atb Cap Markets downgraded shares of Cresco Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 9th. Two investment analysts have rated the stock with a hold rating, one has issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Cresco Labs currently has a consensus rating of “Buy” and a consensus target price of $3.00.

Cresco Labs Trading Down 4.0 %

OTCMKTS CRLBF opened at $0.71 on Wednesday. The firm’s fifty day moving average price is $0.88 and its 200 day moving average price is $1.19. Cresco Labs has a 12 month low of $0.70 and a 12 month high of $2.60. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.97 and a quick ratio of 1.39. The company has a market capitalization of $344.14 million, a price-to-earnings ratio of -3.53 and a beta of 1.79.

Cresco Labs (OTCMKTS:CRLBF) last announced its quarterly earnings results on Friday, March 14th. The company reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01). Cresco Labs had a negative net margin of 9.15% and a negative return on equity of 16.52%. The company had revenue of $176.00 million for the quarter, compared to analyst estimates of $172.10 million.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.